Sodium 2-methylprop-2-ene-1-sulfonate
Names
[ CAS No. ]:
1561-92-8
[ Name ]:
Sodium 2-methylprop-2-ene-1-sulfonate
[Synonym ]:
SODIUM METHALLYLSULFONATE
MFCD00065344
2-Propene-1-sulfonic acid, 2-methyl-, sodium salt
Sodium 2-methylprop-2-ene-1-sulfonate
Natriummethylallylsulfonat
2-Methyl-2-propene-1
2-Methyl-2-propene-1-sulfonic Acid Sodium Salt
2-Methyl-prop-2-en-1-sulfonsaeure,Natriumsalz
Sodium Methyl Acrylate Sulfonate
sodium 2-methyl-2-propenesulfonate
Sodium methylacrylsulfonate
Sodium 2-methyl-2-propene-1-sulfonate
Sodium Methylallyl Sulphonate
methallylsulfonate
sodium 2-methyl-2-propensulfonate
2-Propene-1-sulfonic acid, 2-methyl-, sodium salt (1:1)
Sodium Methyl Allyl Sulfonate
2-methyl-prop-2-ene-1-sulfonic acid,sodium salt
EINECS 216-341-5
Methallylsulfonic Acid Sodium Salt
Chemical & Physical Properties
[ Density]:
1.26g/cm3
[ Melting Point ]:
>300 °C(lit.)
[ Molecular Formula ]:
C4H7NaO3S
[ Molecular Weight ]:
158.151
[ Exact Mass ]:
158.001358
[ PSA ]:
65.58000
[ LogP ]:
1.18850
[ Index of Refraction ]:
1.475
MSDS
Safety Information
[ Hazard Codes ]:
Xi
[ Risk Phrases ]:
36/37/38-43
[ Safety Phrases ]:
26-36/37
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
1
[ HS Code ]:
2904100000
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2904100000
[ Summary ]:
2904100000 derivatives containing only sulpho groups, their salts and ethyl esters。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:5.5%。General tariff:30.0%
Articles
Clin. Hemorheol. Microcirc. 52(2-4) , 295-311, (2012)
The chemical composition of a substrate can influence the adhesion, viability and proliferation of cells seeded on the substrate. The aim of this work was to investigate the influence of different cat...
Biocompatibility of hemodialysis membranes: a study in healthy subjects.Blood Purif. 12(2) , 95-105, (1994)
The effect of blood-membrane interaction on several biocompatibility parameters has been investigated. Four groups of healthy subjects underwent sham hemodialysis, i.e. the establishment of blood-dial...
Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients.J. Clin. Pharmacol. 45(11) , 1294-304, (2005)
The pharmacokinetics of meropenem were characterized in 20 patients with different degrees of renal function who underwent continuous renal replacement therapy. Previously, no differences were detecte...